![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Y Pak, A Kouvelas, MA Scheideler, J Rasmussen, BF O'Dowd and SR George
Department of Pharmacology, University of Toronto, Ontario, Canada.
The effects of acute exposure of the opioid peptide [D-Ala2,N-MePhe4, Gly-ol5]enkephalin (DAMGO) on the mu-opioid receptor were examined in Chinese hamster ovary (CHO) K-1 and baby hamster kidney stable transfectants. In the CHO cell line, acute 1-hr treatment with DAMGO decreased the density of receptors without affecting the affinity or proportion of agonist-detected sites and attenuated the ability of the agonist to inhibit forskolin-stimulated cAMP accumulation. In contrast, similar 1-hr treatment of baby hamster kidney cells did not affect receptor density or agonist ability to inhibit cAMP accumulation, but longer duration of agonist exposure resulted in a reduction in membrane receptor, identical to the CHO cells. These results suggested that for the mu-opioid receptor, alteration in receptor density was the major determinant for the observed agonist-induced desensitization. Consistent with this notion, the ratio of the DAMGO concentration yielding half-maximal occupation of the mu receptor to that yielding half-maximal functional response was < 1. This suggests the necessity for a high mu receptor occupancy rate for maximal functional response, so that any loss of cell surface opioid-binding sites was a critical determinant in reducing the maximal response. This hypothesis was further supported by the observation that irreversible inactivation of fixed proportions of opioid-binding sites with beta-chlorn-altrexamine demonstrated that there were few spare receptors, which is in contrast to what has been reported for other G protein-coupled receptors, including the delta-opioid receptor. Taken together, these data suggest that the opioid agonist DAMGO has a high affinity for the mu receptor but must occupy > 70% of the available receptors to generate the maximal second messenger-linked response.
This article has been cited by other articles:
|
|
 |
|
  Y.-J. Liang, D.-F. Wu, L.-Q. Yang, V. Hollt, and T. Koch Interaction of the {micro}-Opioid Receptor with Synaptophysin Influences Receptor Trafficking and Signaling Mol. Pharmacol., January 1, 2007; 71(1): 123 - 131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Fan, G. Varghese, T. Nguyen, R. Tse, B. F. O'Dowd, and S. R. George A Role for the Distal Carboxyl Tails in Generating the Novel Pharmacology and G Protein Activation Profile of {micro} and {delta} Opioid Receptor Hetero-oligomers J. Biol. Chem., November 18, 2005; 280(46): 38478 - 38488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Marie, I. Lecoq, P. Jauzac, and S. Allouche Differential Sorting of Human {delta}-Opioid Receptors after Internalization by Peptide and Alkaloid Agonists J. Biol. Chem., June 13, 2003; 278(25): 22795 - 22804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Szeto, Y. Soong, D. Wu, and J. Fasolo Resensitization of Blood Pressure Response to {micro}-Opioid Peptide Agonists After Acute Desensitization Anesth. Analg., September 1, 2001; 93(3): 581 - 586. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. T. Williams, M. J. Christie, and O. Manzoni Cellular and Synaptic Adaptations Mediating Opioid Dependence Physiol Rev, January 1, 2001; 81(1): 299 - 343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Law, L. J. Erickson, R. El-Kouhen, L. Dicker, J. Solberg, W. Wang, E. Miller, A. L. Burd, and H. H. Loh Receptor Density and Recycling Affect the Rate of Agonist-Induced Desensitization of {micro}-Opioid Receptor Mol. Pharmacol., August 1, 2000; 58(2): 388 - 398. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Pak, B. F. O'Dowd, J. B. Wang, and S. R. George Agonist-induced, G Protein-dependent and -independent Down-regulation of the {micro} Opioid Receptor. THE RECEPTOR IS A DIRECT SUBSTRATE FOR PROTEIN-TYROSINE KINASE J. Biol. Chem., September 24, 1999; 274(39): 27610 - 27616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P.-Y. Law and H. H. Loh Regulation of Opioid Receptor Activities J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 607 - 624. [Abstract] [Full Text]
|
|
|
|
|
|
V. Beaumont, M. B. Hepworth, J. S. Luty, E. Kelly, and G. Henderson Somatostatin Receptor Desensitization in NG108-15 Cells. A CONSEQUENCE OF RECEPTOR SEQUESTRATION J. Biol. Chem., December 11, 1998; 273(50): 33174 - 33183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rinaldi-Carmona, A. Le Duigou, D. Oustric, F. Barth, M. Bouaboula, P. Carayon, P. Casellas, and G. Le Fur Modulation of CB1 Cannabinoid Receptor Functions after a Long-Term Exposure to Agonist or Inverse Agonist in the Chinese Hamster Ovary Cell Expression System J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1038 - 1047. [Abstract] [Full Text]
|
|
|
|
|
|
R. D. Polakiewicz, S. M. Schieferl, L. F. Dorner, V. Kansra, and M. J. Comb A Mitogen-activated Protein Kinase Pathway Is Required for µ-Opioid Receptor Desensitization J. Biol. Chem., May 15, 1998; 273(20): 12402 - 12406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yu, L. Zhang, X. Yin, H. Sun, G. R. Uhl, and J. B. Wang µ Opioid Receptor Phosphorylation, Desensitization, and Ligand Efficacy J. Biol. Chem., November 14, 1997; 272(46): 28869 - 28874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Nestler and G. K. Aghajanian Molecular and Cellular Basis of Addiction Science, October 3, 1997; 278(5335): 58 - 63. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Pak, B. F. O'Dowd, and S. R. George Agonist-induced Desensitization of the µ Opioid Receptor Is Determined by Threonine 394 Preceded by Acidic Amino Acids in the COOH-terminal Tail J. Biol. Chem., October 3, 1997; 272(40): 24961 - 24965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Krupnick, O. B. Goodman Jr., J. H. Keen, and J. L. Benovic Arrestin/Clathrin Interaction. LOCALIZATION OF THE CLATHRIN BINDING DOMAIN OF NONVISUAL ARRESTINS TO THE CARBOXYL TERMINUS J. Biol. Chem., June 6, 1997; 272(23): 15011 - 15016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. George, T. Fan, Z. Xie, R. Tse, V. Tam, G. Varghese, and B. F. O'Dowd Oligomerization of {micro}- and delta -Opioid Receptors. GENERATION OF NOVEL FUNCTIONAL PROPERTIES J. Biol. Chem., August 18, 2000; 275(34): 26128 - 26135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-Y. Law, O. M.-E. Kouhen, J. Solberg, W. Wang, L. J. Erickson, and H. H. Loh Deltorphin II-induced Rapid Desensitization of delta -Opioid Receptor Requires Both Phosphorylation and Internalization of the Receptor J. Biol. Chem., October 6, 2000; 275(41): 32057 - 32065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. M.-E. Kouhen, G. Wang, J. Solberg, L. J. Erickson, P.-Y. Law, and H. H. Loh Hierarchical Phosphorylation of delta -Opioid Receptor Regulates Agonist-induced Receptor Desensitization and Internalization J. Biol. Chem., November 17, 2000; 275(47): 36659 - 36664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Celver, J. Lowe, A. Kovoor, V. V. Gurevich, and C. Chavkin Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and beta -Arrestin 2-mediated Desensitization of the {micro}-Opioid Receptor in Xenopus Oocytes J. Biol. Chem., February 9, 2001; 276(7): 4894 - 4900. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
